A non-invasive system for monitoring neurotoxicity in animal models
A non-invasive system for monitoring neurotoxicity in animal models
批准号:
G1001514/1
负责人:
John Sharkey
金额:
$40.88万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --
中文摘要
大脑和神经系统不断暴露于来自环境和药物的大量潜在有害化学物质中。为了最大限度地降低风险,作为分层毒性测试的结构化过程的一部分,需要评估新药和环境化学品的神经毒性潜力。然而,目前的方法可能无法识别低水平的神经毒性,特别是当它发生在大脑的不可预见(“脱靶”)区域时。鉴于最近的流行病学证据表明,在神经退行性疾病如帕金森?在S疾病中,环境神经毒素的有害影响可能在暴露多年后才显现出来。因此,开发能够检测低水平神经毒性的生物标志物显然是一个未满足的需求。为了实现这一目标,我们将开发一种新的基因工程小鼠模型,其中分子报告连接到被各种化学毒素和致癌物激活的关键应激传感器基因的调控序列。应激基因被激活后,其中一个报告基因,即人类绒毛膜促性腺激素的生物无活性β链,被排泄到血液中,随后进入尿液,而第二个报告基因仍然定位于传感器基因被激活的细胞中。任何导致毒性的化学或病理情况都会导致实时的?中毒的信号?这可以通过尿液分析来监测排泄报告。然后,可以通过对原位报告者的脑切片染色来确定毒性损伤的部位。这种方法的成功发展将代表神经毒性测试的重大进步。由于这些毒性传感器在细胞死亡之前被激活,我们预计报告蛋白应该比传统组织学技术更早地被检测到,并且在较低剂量的测试化合物下。使用可排泄报告物作为非侵入性毒性生物标志物,允许在单个动物中进行时间过程或剂量递增研究,从而大大减少了这些研究所需的动物数量。表达原位报告基因的细胞可视化使用已建立的生化方法,并可进行自动分析。这种更高的通量将允许更系统的神经毒性分析,并将突出低水平毒性的区域,即使它们发生,脱靶?
英文摘要
The brain and nervous system are continuously exposed to a vast array of potentially harmful chemicals from the environment and in medicines. To minimise the risk, new medicines and environmental chemicals are required to be assesed for their neurotoxic potential as part of a structured process of tiered toxicity testing. However, current methods may fail to identify low-levels of neurotoxicity, particularly where it occurs in unforeseen (?off-target?) areas of the brain. This is of particular significance in the light of recent epidemiological evidence that in neurodegenerative disorders such as Parkinson?s disease, the harmful effects of environmental neurotoxins may only become apparent many years after exposure. Thus, there is a clear unmet need to develop biomarkers that can detect low-level neurotoxicity.To achieve this goal we will develop a novel genetically engineered mouse model in which molecular reporters are attached to the regulatory sequences of key stress sensor genes that are activated by a wide variety of chemical toxins and carcinogens. Upon activation of the stress-gene, one of these reporters, the biologically inactive beta-chain of human chorionic gonadotrophin, is excreted into the blood and subsequently the urine, while the second reporter remains localised to the cells in which the sensor gene is activated. Any chemical or pathological condition that causes toxicity will result in a real-time ?signal of toxicity? that can be monitored by urine analysis for the excretable reporter. The site of toxic insult can then be identified by staining brain sections for the in situ reporter.The successful development of this approach would represent a significant advance in neurotoxicity testing. As these toxicity sensors are activated prior to cell death we anticipate that the reporters should be detected earlier and at lower doses of test compound than required for conventional histological techniques. The use of the excretable reporter as a non-invasive toxicity biomarker permits time-course or dose escalation studies to be performed in individual animals, thereby reducing considerably the number of animals required for these studies. Visualisation of cells expressing the in situ reporter uses established biochemical methods and is amenable to automated analysis. This higher throughput would permit a more systematic analysis of neurotoxicity and would highlight areas of low-level toxicity, even where they occur, ?off-target?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于深穿透拉曼光谱的安全光照剂量的深层病灶无创检测与深度预测
-
批准号:82372016
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:林俐
-
依托单位: